| copper ion transport | GO:0006825 | 10 | 0.911 | |
| copper ion homeostasis | GO:0055070 | 9 | 0.886 | |
| transition metal ion transport | GO:0000041 | 38 | 0.455 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.339 | |
| stress response to metal ion | GO:0097501 | 3 | 0.338 | |
| cation transport | GO:0006812 | 399 | 0.323 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.301 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.300 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.295 | |
| response to oxygen radical | GO:0000305 | 16 | 0.287 | |
| lung development | GO:0030324 | 164 | 0.283 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.272 | |
| organelle assembly | GO:0070925 | 177 | 0.265 | |
| copper ion transmembrane transport | GO:0035434 | 5 | 0.244 | |
| response to superoxide | GO:0000303 | 16 | 0.244 | |
| immune effector process | GO:0002252 | 321 | 0.239 | |
| cation homeostasis | GO:0055080 | 212 | 0.216 | |
| oxidation reduction process | GO:0055114 | 342 | 0.212 | |
| cellular zinc ion homeostasis | GO:0006882 | 9 | 0.209 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.197 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.196 | |
| t cell activation | GO:0042110 | 289 | 0.193 | |
| trivalent inorganic cation transport | GO:0072512 | 5 | 0.187 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.182 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.177 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.174 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.170 | |
| amine metabolic process | GO:0009308 | 45 | 0.143 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.142 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.142 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.137 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.136 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.135 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.131 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.130 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.129 | |
| cellular transition metal ion homeostasis | GO:0046916 | 32 | 0.128 | |
| gland development | GO:0048732 | 330 | 0.123 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.123 | |
| cellular homeostasis | GO:0019725 | 240 | 0.119 | |
| tissue remodeling | GO:0048771 | 102 | 0.116 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.116 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.115 | |
| respiratory system development | GO:0060541 | 190 | 0.115 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.115 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.111 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.110 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.110 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.110 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.109 | |
| positive regulation of metalloenzyme activity | GO:0048554 | 3 | 0.108 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.106 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.104 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.102 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.101 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.101 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.101 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.100 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.100 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.099 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 28 | 0.098 | |
| myosin filament assembly | GO:0031034 | 2 | 0.098 | |
| alpha beta t cell differentiation involved in immune response | GO:0002293 | 30 | 0.097 | |
| respiratory tube development | GO:0030323 | 167 | 0.095 | |
| response to copper ion | GO:0046688 | 3 | 0.094 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.093 | |
| molting cycle | GO:0042303 | 90 | 0.093 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.091 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.088 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.088 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.087 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.087 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.084 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.084 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.083 | |
| t cell differentiation | GO:0030217 | 174 | 0.081 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.080 | |
| hair follicle development | GO:0001942 | 85 | 0.079 | |
| transmembrane transport | GO:0055085 | 412 | 0.078 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.078 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.078 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.076 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.076 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.076 | |
| cell adhesion | GO:0007155 | 329 | 0.075 | |
| skeletal system development | GO:0001501 | 356 | 0.075 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.074 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.074 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.073 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.071 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.070 | |
| response to inorganic substance | GO:0010035 | 96 | 0.069 | |
| hair cycle | GO:0042633 | 90 | 0.069 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.068 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.067 | |
| germ cell development | GO:0007281 | 185 | 0.067 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.067 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.067 | |
| cerebellar purkinje cell differentiation | GO:0021702 | 13 | 0.066 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.066 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.065 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.065 | |
| circulatory system process | GO:0003013 | 197 | 0.065 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.065 | |
| striated muscle cell development | GO:0055002 | 125 | 0.065 | |
| extracellular structure organization | GO:0043062 | 148 | 0.065 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.065 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.064 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.064 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.064 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.062 | |
| atp metabolic process | GO:0046034 | 75 | 0.062 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.061 | |
| zinc ion homeostasis | GO:0055069 | 10 | 0.060 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.060 | |
| response to oxidative stress | GO:0006979 | 123 | 0.060 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.059 | |
| connective tissue development | GO:0061448 | 179 | 0.059 | Mouse |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.059 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.059 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.058 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.058 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.058 | |
| atp catabolic process | GO:0006200 | 55 | 0.058 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.058 | |
| lung alveolus development | GO:0048286 | 45 | 0.058 | |
| protein processing | GO:0016485 | 163 | 0.057 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.057 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.057 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.056 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.056 | |
| muscle tissue development | GO:0060537 | 308 | 0.056 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.056 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.056 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.055 | |
| cell recognition | GO:0008037 | 83 | 0.055 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.055 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.054 | |
| tryptophan metabolic process | GO:0006568 | 4 | 0.054 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.054 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.054 | |
| maintenance of location | GO:0051235 | 89 | 0.054 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.054 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.053 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.052 | |
| skin morphogenesis | GO:0043589 | 38 | 0.052 | |
| protein catabolic process | GO:0030163 | 221 | 0.051 | |
| organic anion transport | GO:0015711 | 137 | 0.051 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.050 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.050 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.050 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.049 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.049 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.049 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.049 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.049 | |
| inflammatory response | GO:0006954 | 244 | 0.049 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.049 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.048 | |
| peptide metabolic process | GO:0006518 | 46 | 0.048 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.048 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.048 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.047 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.047 | |
| epidermis development | GO:0008544 | 187 | 0.047 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.047 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.046 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.046 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.046 | |
| cytokine production | GO:0001816 | 319 | 0.046 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.045 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.045 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.045 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.045 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.045 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.044 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.044 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.044 | |
| regulation of defense response | GO:0031347 | 233 | 0.043 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.043 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.043 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.043 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.043 | |
| rhythmic process | GO:0048511 | 174 | 0.042 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.042 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.042 | |
| membrane organization | GO:0061024 | 245 | 0.042 | |
| response to metal ion | GO:0010038 | 47 | 0.042 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.041 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.041 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.041 | |
| regulation of oxidative phosphorylation | GO:0002082 | 6 | 0.041 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.040 | |
| exocytosis | GO:0006887 | 121 | 0.040 | |
| primary amino compound metabolic process | GO:1901160 | 8 | 0.040 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.040 | |
| regulation of metalloenzyme activity | GO:0048552 | 4 | 0.040 | |
| microtubule based process | GO:0007017 | 236 | 0.040 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.039 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.039 | |
| forebrain development | GO:0030900 | 302 | 0.039 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.039 | |
| iron ion homeostasis | GO:0055072 | 36 | 0.039 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.038 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.038 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.038 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.037 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.037 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.037 | |
| regulation of system process | GO:0044057 | 200 | 0.037 | |
| mitochondrion organization | GO:0007005 | 134 | 0.036 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.036 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.036 | |
| hindbrain development | GO:0030902 | 128 | 0.036 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.036 | |
| male gamete generation | GO:0048232 | 285 | 0.035 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.035 | |
| cerebellar purkinje cell layer development | GO:0021680 | 26 | 0.035 | |
| regulation of secretion | GO:0051046 | 274 | 0.035 | |
| sensory perception | GO:0007600 | 245 | 0.035 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.034 | |
| renal sodium excretion | GO:0035812 | 3 | 0.034 | |
| spermatogenesis | GO:0007283 | 284 | 0.034 | |
| developmental pigmentation | GO:0048066 | 40 | 0.034 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.034 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.034 | |
| protein ubiquitination | GO:0016567 | 171 | 0.034 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.033 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.033 | |
| endocytosis | GO:0006897 | 168 | 0.033 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.033 | |
| activation of immune response | GO:0002253 | 138 | 0.033 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.033 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.033 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.032 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.032 | |
| protein maturation | GO:0051604 | 176 | 0.032 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.032 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.031 | |
| dna metabolic process | GO:0006259 | 303 | 0.031 | |
| chromatin organization | GO:0006325 | 206 | 0.031 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.031 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.030 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.030 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.030 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.030 | |
| body fluid secretion | GO:0007589 | 53 | 0.030 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.030 | |
| spermatid development | GO:0007286 | 108 | 0.030 | |
| neuron death | GO:0070997 | 154 | 0.030 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.029 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.029 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.029 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.029 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.029 | |
| regulation of systemic arterial blood pressure by atrial natriuretic peptide | GO:0003050 | 2 | 0.029 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.029 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.029 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.029 | |
| anion transport | GO:0006820 | 177 | 0.029 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.029 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.029 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.029 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.029 | |
| blood circulation | GO:0008015 | 195 | 0.029 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.028 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.028 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.028 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.028 | |
| cell junction assembly | GO:0034329 | 52 | 0.028 | |
| lipid localization | GO:0010876 | 126 | 0.028 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.028 | |
| leukocyte migration | GO:0050900 | 124 | 0.028 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.027 | |
| steroid metabolic process | GO:0008202 | 119 | 0.027 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.027 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.027 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.027 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.027 | |
| lactation | GO:0007595 | 25 | 0.027 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.027 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.027 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.027 | |
| muscle cell development | GO:0055001 | 133 | 0.027 | |
| regulation of cell motility | GO:2000145 | 236 | 0.027 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.027 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.027 | |
| lipid transport | GO:0006869 | 98 | 0.026 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.026 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.026 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.026 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.025 | |
| digestive tract development | GO:0048565 | 190 | 0.025 | |
| potassium ion transport | GO:0006813 | 52 | 0.025 | |
| cell growth | GO:0016049 | 130 | 0.025 | |
| tyrosine metabolic process | GO:0006570 | 4 | 0.025 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.025 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.025 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.025 | |
| serotonin metabolic process | GO:0042428 | 8 | 0.025 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.025 | |
| regulation of protein processing | GO:0070613 | 96 | 0.025 | |
| regulation of atp metabolic process | GO:1903578 | 17 | 0.025 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.025 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.024 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.024 | |
| cell junction organization | GO:0034330 | 77 | 0.024 | |
| microglia development | GO:0014005 | 2 | 0.024 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.024 | |
| metencephalon development | GO:0022037 | 89 | 0.024 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.024 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.024 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.024 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.024 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.024 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.024 | |
| digestive system development | GO:0055123 | 200 | 0.024 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.024 | |
| regulation of neuron death | GO:1901214 | 134 | 0.024 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.024 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.023 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.023 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.023 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.023 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.023 | |
| endomembrane system organization | GO:0010256 | 147 | 0.023 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.023 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.023 | |
| cellular response to lipid | GO:0071396 | 145 | 0.023 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.023 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.023 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.023 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.023 | |
| vacuole organization | GO:0007033 | 38 | 0.023 | |
| regulation of cell migration | GO:0030334 | 219 | 0.022 | |
| regulation of protein transport | GO:0051223 | 163 | 0.022 | |
| limb morphogenesis | GO:0035108 | 149 | 0.022 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.022 | |
| regulation of intrinsic apoptotic signaling pathway by p53 class mediator | GO:1902253 | 13 | 0.022 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.022 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.022 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.022 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.022 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.022 | |
| innate immune response | GO:0045087 | 157 | 0.022 | |
| regulation of protein localization | GO:0032880 | 231 | 0.022 | |
| coagulation | GO:0050817 | 78 | 0.022 | |
| response to acid chemical | GO:0001101 | 111 | 0.022 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.022 | |
| skin development | GO:0043588 | 220 | 0.021 | |
| hemostasis | GO:0007599 | 78 | 0.021 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.021 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.021 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.021 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.021 | |
| blastocyst development | GO:0001824 | 80 | 0.021 | |
| pigmentation | GO:0043473 | 71 | 0.021 | |
| mapk cascade | GO:0000165 | 281 | 0.021 | |
| response to iron ion | GO:0010039 | 4 | 0.021 | |
| exosomal secretion | GO:1990182 | 1 | 0.021 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.021 | |
| positive regulation of podosome assembly | GO:0071803 | 3 | 0.020 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.020 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.020 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.020 | |
| detection of stimulus | GO:0051606 | 84 | 0.020 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.020 | |
| sterol transport | GO:0015918 | 38 | 0.020 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.020 | |
| kidney development | GO:0001822 | 213 | 0.020 | |
| iron ion import into cell | GO:0097459 | 4 | 0.020 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.020 | |
| protein secretion | GO:0009306 | 111 | 0.020 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.020 | |
| ear morphogenesis | GO:0042471 | 118 | 0.020 | |
| dendrite development | GO:0016358 | 115 | 0.020 | |
| circadian rhythm | GO:0007623 | 114 | 0.020 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.020 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.020 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.019 | |
| fat cell differentiation | GO:0045444 | 160 | 0.019 | |
| cell chemotaxis | GO:0060326 | 81 | 0.019 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.019 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.019 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.019 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.019 | |
| plasma membrane organization | GO:0007009 | 90 | 0.019 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.019 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.019 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.019 | |
| phagocytosis | GO:0006909 | 66 | 0.019 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.019 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.019 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.019 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.019 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.019 | |
| wound healing | GO:0042060 | 157 | 0.019 | |
| oogenesis | GO:0048477 | 56 | 0.019 | |
| pyramidal neuron development | GO:0021860 | 8 | 0.019 | |
| regulation of translation | GO:0006417 | 71 | 0.018 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.018 | |
| bone resorption | GO:0045453 | 38 | 0.018 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.018 | |
| sensory perception of sound | GO:0007605 | 97 | 0.018 | |
| urogenital system development | GO:0001655 | 261 | 0.018 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.018 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.018 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.018 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.018 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.018 | |
| ear development | GO:0043583 | 200 | 0.018 | |
| cholesterol transport | GO:0030301 | 38 | 0.018 | |
| neural tube development | GO:0021915 | 160 | 0.018 | |
| angiogenesis | GO:0001525 | 201 | 0.018 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.018 | |
| heart process | GO:0003015 | 94 | 0.018 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.018 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.018 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.018 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.018 | |
| cellular iron ion homeostasis | GO:0006879 | 16 | 0.018 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.017 | |
| pilomotor reflex | GO:0097195 | 3 | 0.017 | |
| tissue homeostasis | GO:0001894 | 115 | 0.017 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.017 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.017 | |
| translation | GO:0006412 | 93 | 0.017 | |
| ossification | GO:0001503 | 216 | 0.017 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.017 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.017 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.017 | |
| aromatic amino acid family metabolic process | GO:0009072 | 9 | 0.017 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.017 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.017 | |
| regulation of macrophage activation | GO:0043030 | 17 | 0.017 | |
| glutathione metabolic process | GO:0006749 | 16 | 0.017 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.017 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.017 | |
| muscle system process | GO:0003012 | 141 | 0.017 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.017 | |
| female gamete generation | GO:0007292 | 74 | 0.017 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.017 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.017 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.017 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.017 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.017 | |
| t cell proliferation | GO:0042098 | 120 | 0.017 | |
| myosin filament organization | GO:0031033 | 3 | 0.017 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.017 | |
| actin filament organization | GO:0007015 | 113 | 0.017 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.017 | |
| oocyte construction | GO:0007308 | 2 | 0.016 | |
| dephosphorylation | GO:0016311 | 129 | 0.016 | |
| hormone secretion | GO:0046879 | 128 | 0.016 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.016 | |
| response to nutrient levels | GO:0031667 | 109 | 0.016 | |
| locomotory behavior | GO:0007626 | 195 | 0.016 | |
| epithelial cell development | GO:0002064 | 159 | 0.016 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.016 | |
| regulation of cell activation | GO:0050865 | 289 | 0.016 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.016 | |
| appendage development | GO:0048736 | 166 | 0.016 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.016 | |
| amp metabolic process | GO:0046033 | 4 | 0.016 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.016 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.016 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.015 | |
| cellularization | GO:0007349 | 1 | 0.015 | |
| chromatin modification | GO:0016568 | 187 | 0.015 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.015 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.015 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.015 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.015 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.015 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.015 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.015 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.015 | |
| iron ion transport | GO:0006826 | 17 | 0.015 | Mouse |
| muscle contraction | GO:0006936 | 101 | 0.015 | |
| glucose homeostasis | GO:0042593 | 128 | 0.015 | |
| acetylcholine transport | GO:0015870 | 2 | 0.015 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.015 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.015 | |
